0.18 USD
↘ 0.02 (8.69%)AT CLOSE (03:59 PM EST)
Context Therapeutics Inc. Common Stock
CNTXNASDAQ • USD
0.18
↗ 0.00 (0.66%)
POST MARKET (AS OF 04:14 PM EST)
Post Market
AS OF 04:14 PM EST
0.18
↗ 0.00 (0.66%)
Market: CLOSED
CNTX is currently priced at $0.18. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.
Technical & fundamental data as of Nov 13, 2026.
Open?$0.20
High?$0.21
Low?$0.18
Prev. Close?$0.20
Volume?939.0K
Avg. Volume?1.3M
VWAP?$0.19
Rel. Volume?0.71x
Bid / Ask
Bid?$0.17 × 100
Ask?$0.21 × 4.7K
Spread?$0.04
Midpoint?$0.19
Valuation & Ratios
Market Cap?16.5M
Shares Out?91.9M
Float?69.3M
Float %?75.4%
P/E Ratio?N/A
P/B Ratio?0.53
EPS?-$0.48
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
Themes
Employees
15
Market Cap
16.6M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2021-10-20
Address
2001 MARKET STREET
PHILADELPHIA, PA 19103
Phone: 267-225-7416
PHILADELPHIA, PA 19103
Phone: 267-225-7416
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?64
Piotroski F-Score?0/9Weak
Altman Z-Score?-7.56Distress
Confidence?49%Low
Short InterestElevated
Short % of Float?6.78%Elevated
Short Interest?4.7M
Days to Cover?3.7
Free Float69.3M
Avg Daily Volume1.3M
Settlement Date2026-10-30
Financial Health
Current Ratio?6.59Strong
Quick Ratio?6.59Strong
Cash Ratio?6.26Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?0.53CHEAP▾
Peers100
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?0.4CHEAP▾
Peers100
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-141.6%WEAK▾
S&P3
ROA?-120.1%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-34027264
Enterprise Value?$-17872667
Fundamentals ratios updated end of day